Hind Lal

3.4k total citations
57 papers, 2.4k citations indexed

About

Hind Lal is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Hind Lal has authored 57 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 32 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Hind Lal's work include Cardiac Fibrosis and Remodeling (27 papers), Signaling Pathways in Disease (10 papers) and Wnt/β-catenin signaling in development and cancer (9 papers). Hind Lal is often cited by papers focused on Cardiac Fibrosis and Remodeling (27 papers), Signaling Pathways in Disease (10 papers) and Wnt/β-catenin signaling in development and cancer (9 papers). Hind Lal collaborates with scholars based in United States, Canada and United Arab Emirates. Hind Lal's co-authors include Thomas Force, James R. Woodgett, Firdos Ahmad, Prachi Umbarkar, Anand Prakash Singh, Erhe Gao, Jibin Zhou, Qinkun Zhang, Ronald J. Vagnozzi and Yuanjun Guo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Hind Lal

55 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hind Lal United States 30 1.4k 992 307 288 249 57 2.4k
Mirko Völkers Germany 27 1.7k 1.2× 762 0.8× 262 0.9× 171 0.6× 244 1.0× 53 2.4k
Yasunori Shintani Japan 28 1.2k 0.9× 1.1k 1.1× 585 1.9× 195 0.7× 286 1.1× 58 2.7k
Allen J. York United States 27 2.1k 1.5× 1.3k 1.3× 458 1.5× 149 0.5× 177 0.7× 37 2.9k
Robert N. Correll United States 23 2.0k 1.5× 1.8k 1.8× 450 1.5× 295 1.0× 141 0.6× 36 3.1k
Dongtak Jeong United States 24 2.0k 1.4× 1.0k 1.0× 369 1.2× 191 0.7× 138 0.6× 55 2.7k
Yan‐Shan Dai United States 20 2.0k 1.5× 838 0.8× 379 1.2× 257 0.9× 117 0.5× 37 2.6k
Nour-Eddine Rhaleb United States 32 888 0.6× 1.3k 1.3× 323 1.1× 371 1.3× 490 2.0× 43 2.7k
Atsuhiko T. Naito Japan 26 1.9k 1.4× 773 0.8× 692 2.3× 183 0.6× 185 0.7× 68 2.8k
Changwon Kho United States 21 1.5k 1.1× 793 0.8× 195 0.6× 191 0.7× 119 0.5× 40 2.0k
Jianjian Shi United States 26 1.4k 1.0× 577 0.6× 113 0.4× 349 1.2× 154 0.6× 38 2.4k

Countries citing papers authored by Hind Lal

Since Specialization
Citations

This map shows the geographic impact of Hind Lal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hind Lal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hind Lal more than expected).

Fields of papers citing papers by Hind Lal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hind Lal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hind Lal. The network helps show where Hind Lal may publish in the future.

Co-authorship network of co-authors of Hind Lal

This figure shows the co-authorship network connecting the top 25 collaborators of Hind Lal. A scholar is included among the top collaborators of Hind Lal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hind Lal. Hind Lal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hui, Chaoshan Han, Hind Lal, et al.. (2025). Loss of Elmsan1 in cardiomyocytes leads to age-dependent cardiac dysfunction and reduced lifespan. American Journal of Physiology-Heart and Circulatory Physiology. 329(2). H315–H329.
2.
Ranjan, Prabhat, Sumanta Goswami, Harish C. Pal, et al.. (2025). Hypertrophic heart failure promotes gut dysbiosis and gut leakage in interleukin 10-deficient mice. American Journal of Physiology-Heart and Circulatory Physiology. 328(3). H447–H459. 3 indexed citations
3.
Gupte, Manisha, et al.. (2024). Animal models of haploinsufficiency revealed the isoform-specific role of GSK-3 in HFD-induced obesity and glucose intolerance. American Journal of Physiology-Cell Physiology. 327(6). C1349–C1358. 1 indexed citations
4.
Tousif, Sultan, Anand Prakash Singh, Prachi Umbarkar, et al.. (2023). Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation Research. 132(3). 267–289. 36 indexed citations
5.
Umbarkar, Prachi, et al.. (2023). GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(6). 166724–166724. 14 indexed citations
6.
Gupte, Manisha, et al.. (2022). Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose Intolerance. Cells. 11(3). 559–559. 11 indexed citations
7.
Umbarkar, Prachi, Sultan Tousif, Anand Prakash Singh, et al.. (2022). Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart. Circulation Research. 131(7). 620–636. 48 indexed citations
8.
Riley, Lance A., Matthew R. Bersi, Prachi Umbarkar, et al.. (2021). Targeting 5-HT 2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction. Circulation. 143(13). 1317–1330. 42 indexed citations
9.
Umbarkar, Prachi, et al.. (2021). Mechanisms of Fibroblast Activation and Myocardial Fibrosis: Lessons Learned from FB-Specific Conditional Mouse Models. Cells. 10(9). 2412–2412. 30 indexed citations
10.
Hall, Eric J., et al.. (2021). Cardiac natriuretic peptide deficiency sensitizes the heart to stress-induced ventricular arrhythmias via impaired CREB signalling. Cardiovascular Research. 118(9). 2124–2138. 12 indexed citations
11.
Gupte, Manisha, Prachi Umbarkar, Anand Prakash Singh, et al.. (2020). Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity. Cells. 9(5). 1120–1120. 11 indexed citations
12.
Raucci, Frank J., Anand Prakash Singh, Jonathan H. Soslow, et al.. (2020). The BDNF rs6265 Polymorphism is a Modifier of Cardiomyocyte Contractility and Dilated Cardiomyopathy. International Journal of Molecular Sciences. 21(20). 7466–7466. 8 indexed citations
13.
Singh, Anand Prakash, Prachi Umbarkar, Sultan Tousif, & Hind Lal. (2020). Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinib. International Journal of Cardiology. 316. 214–221. 42 indexed citations
14.
Wu, Lan, Connie D. Cao, J. Luke Postoak, et al.. (2019). IL-10–producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction. Proceedings of the National Academy of Sciences. 116(43). 21673–21684. 76 indexed citations
15.
Schroer, Alison K., Matthew R. Bersi, Qinkun Zhang, et al.. (2019). Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction. JCI Insight. 4(18). 31 indexed citations
16.
Gupte, Manisha, Hind Lal, Firdos Ahmad, Douglas B. Sawyer, & Michael F. Hill. (2017). Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes. Journal of Cardiac Failure. 23(12). 887–899. 29 indexed citations
17.
Lal, Hind, Firdos Ahmad, Jibin Zhou, et al.. (2014). Cardiac Fibroblast Glycogen Synthase Kinase-3β Regulates Ventricular Remodeling and Dysfunction in Ischemic Heart. Circulation. 130(5). 419–430. 146 indexed citations
18.
Lal, Hind, Firdos Ahmad, Shan Parikh, & Thomas Force. (2014). TNNI3K, a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease. PubMed Central. 78(7). 1514. 2 indexed citations
19.
Lal, Hind, Kyle L. Kolaja, & Thomas Force. (2013). Cancer Genetics and the Cardiotoxicity of the Therapeutics. Journal of the American College of Cardiology. 61(3). 267–274. 47 indexed citations
20.
Goel, Sudhir K., Shikha Tewari, Hind Lal, et al.. (2008). SYBR Green I chemistry based Real time PCR: Melting curve discrepancies. Current Trends in Biotechnology and Pharmacy. 2(4). 555–567.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirko Völkers Breakdown of academic impact, for papers by Yasunori Shintani Breakdown of academic impact, for papers by Allen J. York Breakdown of academic impact, for papers by Robert N. Correll Breakdown of academic impact, for papers by Dongtak Jeong Breakdown of academic impact, for papers by Yan‐Shan Dai Breakdown of academic impact, for papers by Nour-Eddine Rhaleb Breakdown of academic impact, for papers by Atsuhiko T. Naito Breakdown of academic impact, for papers by Changwon Kho Breakdown of academic impact, for papers by Jianjian Shi
Rankless by CCL
2026